Spire Wealth Management’s IVERIC bio ISEE Stock Holding History
Bought
Maintained
Sold
Spire Wealth Management's ISEE Position: Q3 2023 in Review
Spire Wealth Management sold out of IVERIC bio (ISEE) in Q3 2023, closing a stake of 25 shares — an estimated $984 sold.
Spire Wealth Management first reported a position in ISEE in Q1 2021 and held it in 8 quarters. The position peaked at $27K in Q1 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Spire Wealth Management reported no remaining IVERIC bio position as of Q3 2023 after selling out during the quarter.
- Spire Wealth Management sold 25 IVERIC bio shares in Q3 2023, an estimated $984.
- Spire Wealth Management first reported a position in IVERIC bio in Q1 2021 and held it in 8 quarters.
- Spire Wealth Management's IVERIC bio position peaked at $27K in Q1 2022.
- 0 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2023.
Based on Spire Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.